Background illustration for clinical trials search

Paid Clinical Trials Norman

Discover 566 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

for
Deep Venous Thrombosis
Location: Oklahoma City OK, Dallas TX, Little Rock AR, Austin TX,
Sponsor: Yale University

Sex: All

Age: 0 - 17

Code: NCT04924322

Phase 2, Phase 3, Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

for
Medulloblastoma
Location: Oklahoma City OK, Little Rock AR, Kansas City MO,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 21

Code: NCT04696029

Phase 2, Recruiting

Uterine Preservation Via Lifestyle Transformation

for
Endometrial Hyperplasia, Grade 1 Endometrial Cancer
Location: Oklahoma City OK, St Louis MO, Albuquerque NM
Sponsor: Washington University School of Medicine

Sex: Female

Age: 18+

Code: NCT05903131

Phase 2, Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

for
Cervical Carcinoma, Human Papillomavirus Infection
Location: Oklahoma City OK, Houston TX, Lafayette LA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 25+

Code: NCT07281430

Recruiting

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

for
Hemorrhagic Stroke, Aneurysm, Intracranial, Saccular Aneurysm,
Location: Oklahoma City OK, Dallas TX, Jacksonville FL,
Sponsor: phenox Inc.

Sex: All

Age: 18+

Code: NCT07143019

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment

for
Cannabis Use, Risk Perception, Decision Making
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 21+

Code: NCT07701304

Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Oklahoma City OK, Irving TX, Houston TX, San Antonio TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase 1, Phase 2, Recruiting

STRIDE Biorepository

for
Anemia, Sickle Cell
Location: Oklahoma City OK, Houston TX, Saint Louis MO,
Sponsor: Emory University

Sex: All

Age: 15 - 40

Code: NCT02843347

Recruiting

Stroke Thrombectomy and Aneurysm Registry

for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Oklahoma City OK, Plano TX, Shreveport LA,
Sponsor: Medical University of South Carolina

Sex: All

Age: 1 - 70+

Code: NCT04994756

Recruiting

ctDNA Assay in Patients With Resectable Pancreatic Cancer

for
Pancreas Cancer
Location: Oklahoma City OK, Tulsa OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT05052671

Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: Oklahoma City OK, Memphis TN, Omaha NE, Louisville KY,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase 1, Recruiting

tDCS for Post-Stroke Cognitive Impairment

for
Stroke, Mild Cognitive Impairment
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT06516588

Phase 2, Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Oklahoma City OK, Bedford TX, Dallas TX, Austin TX,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

for
Severe Aplastic Anemia
Location: Oklahoma City OK, Westwood KS, St Louis MO,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70+

Code: NCT06517641

Phase 2, Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

for
Endometrial Cancer
Location: Oklahoma City OK, Houston TX, Sioux Falls SD,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: Female

Age: 18 - 70

Code: NCT06481592

Phase 2, Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Oklahoma City OK, Houston TX, Saint Louis MO, Laredo TX,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase 1, Phase 2, Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Norman OK, Tulsa OK, Mesquite TX, Corsicana TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase 2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Norman OK, Frisco TX, Dallas TX, Lubbock TX,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Norman OK, Oklahoma City OK, Tulsa OK, McKinney TX,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase 3, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Norman OK, Moore OK, Oklahoma City OK, Edmond OK,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase 3, Recruiting